Evotec (OTCMKTS:EVTCY) Stock Crosses Below 50-Day Moving Average - Should You Sell?

Key Points

• Evotec SE stock has fallen below its 50-day moving average of $3.98, trading as low as $3.56 before closing at $3.57.
• The company's market capitalization stands at $1.18 billion with a P/E ratio of 8.71 and low volatility indicated by a beta of 0.98.
• Evotec specializes in drug discovery and development services for pharmaceutical and biotechnology companies through its EVT Execute and EVT Innovate segments.

Evotec SE (OTCMKTS:EVTCY - Get Free Report) shares passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.98 and traded as low as $3.56. Evotec shares last traded at $3.57, with a volume of 33,224 shares.

Evotec Price Performance

The company's 50-day moving average is $3.96 and its 200-day moving average is $3.91. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 2.50. The firm has a market capitalization of $1.16 billion, a price-to-earnings ratio of 8.54 and a beta of 0.98.

About Evotec

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.